Vitrafy Life Sciences Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 6, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Market Capitalization	104	96	-	-	-
Enterprise Value	82	62	-	-	-
Last Close Price	1.63	1.50	-	-	-
PS Ratio	44.42	91.41	-	-	-
PB Ratio	4.81	3.33	-	-	-
P/TBV Ratio	4.81	3.33	-	-	-
EV/Sales Ratio	34.84	58.94	-	-	-
Debt / Equity Ratio	0.02	0.01	-0.95	-0.63	-1.09
Net Debt / Equity Ratio	-1.04	-0.67	-0.69	-0.51	-0.95
Net Debt / EBITDA Ratio	1.39	1.24	-1.97	-1.06	-1.54
Net Debt / FCF Ratio	1.96	2.18	-2.48	-1.47	-1.09
Asset Turnover	0.08	0.05	0.28	0.44	-
Quick Ratio	13.47	7.77	0.26	0.21	0.26
Current Ratio	13.47	11.47	0.27	0.21	0.31
Return on Equity (ROE)	-50.22%	-1570.08%	-	-	-
Return on Assets (ROA)	-34.06%	-46.76%	-73.69%	-95.96%	-
Return on Capital Employed (ROCE)	-74.00%	-53.50%	35.90%	50.90%	66.90%
Earnings Yield	-13.60%	-34.15%	-	-	-
FCF Yield	-	-9.19%	-	-	-
Buyback Yield / Dilution	-336.36%	-1359.98%	-4.02%	-0.73%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.